Although two investigational vaccines are used to immunize humans against Venezuelan equine encephalomyelitis virus, neither had previously been tested for protective efficacy against aerosol exposure. Live attenuated vaccine (TC-83) protected all hamsters challenged by either aerosol or subcutaneous routes with 4.7 to 5.2 log10 PFU of virulent Venezuelan equine encephalomyelitis virus. Formaldehyde-inactivated vaccine (C-84) failed to protect against aerosol challenge but did protect against subcutaneous challenge. Protection elicited by TC-83 vaccine did not depend solely on serum-neutralizing antibody. These studies suggest that TC-83 vaccine is preferable to C-84 vaccine for protecting laboratory workers at risk to aerosol exposure.
Two different investigational vaccines approved for limited human use are available for immunization against Venezuelan equine encephalomyelitis (VEE) virus. One of these vaccines, a live attenuated strain (TC-83), has been used since 1961 to protect laboratory and field workers who are at risk of infection with virulent strains of this virus (20, 21) . Although extensive experience with TC-83 vaccine in more than 6,000 individuals suggested excellent protective efficacy and safety (20) , concerns arose about the use of live attenuated vaccines in general and TC-83 in particular. Its reported reactogenicity (1, 21), potential to revert in virulence (4) and possibly to enter a mosquito-mammal cycle (20) , and its teratogenic potential (19) suggested the need to develop an inactivated vaccine. This second vaccine, C-84 (6), is a formaldehyde-inactivated preparation of TC-83. The serum antibody titers induced in humans by C-84 (12) were generally lower than those induced by TC-83 (5) but were considered adequate for protection, especially since uniform protection was induced by C-84 in standardized laboratory animal tests. All available protective efficacy data for both VEE vaccines are based on survival after subcutaneous (s.c.) or intraperitoneal (i.p.) challenge by injection, although VEE virus is known to be infectious by the aerosol route (9, 10, 14) and is believed to have caused laboratory infections by aerosol (28) . Therefore, comparative assessments of the efficacies of the two vaccines against aerosol exposure were needed.
Hamsters were selected for immunization and challenge based on extensive experience in previous vaccine efficacy tests (7, 8) , the pronounced sensitivity of hamsters to VEE challenge by any route (7), and the bimodal nature of the acute disease involving primarily the reticuloendothelial system but also the central nervous system (11, 16, 17, 29 challenged. Hamsters receiving inactivated VEE vaccine (MNLBR-109, lot C-84-1; Merrell-National Laboratories, Swiftwater, Pa.) were inoculated twice at a 14-day interval and then rested until challenged. Challenge VEE virus (Cx) was prototype Trinidad donkey strain 1-2AC-8 which had been passaged nine times in embryonated chicken eggs, four times in chick embryo cell cultures, and one additional time in suckling mouse brains, as reported previously (15) . For aerosol exposure and s.c. inoculation, Cx was diluted in Eagle minimal essential medium containing Earle salts supplemented with nonessential amino acids, glutamine, and 10% inactivated fetal bovine serum. For aerosol challenge, unanesthetized hamsters were exposed for 10 min, using a dynamic system consisting of a modified Henderson tube with a Collison generator (18) at 22°C. Infectious aerosol exposure doses were calculated by standard procedures (13). For s.c. challenge, Cx was diluted and inoculated in 0.5-ml volumes. All hamsters were challenged 45 days after the first vaccine dose.
All hamsters previously inoculated with the live attenuated TC-83 strain resisted the virulent Cx strain challenge in both high-and low-dose exposures given via the aerosol or s.c. route (Table 1 ). In contrast, hamsters inoculated with the inactivated C-84 vaccine regimen were less uniformly protected. All 14 C-84-inoculated hamsters died after challenge with 4.7 logl0 PFU by the aerosol route. Of 14, 3 (21%) died after low-dose (2.5 logl0 PFU) aerosol exposure, as did 2 of 14 and 1 of 14 exposed to high-and low-dose s.c. challenge, respectively.
The differences observed in protection against aerosol challenge could depend on qualitative differences in humoral or cellular immune responses elicited or on quantitative differences. For 10 unchallenged hamsters inoculated with (25, 26) . The mechanism by which aerosolized Cx kills C-84-inoculated or passively immunized hamsters is important to determine. Local immunity, in the form of secretory immunoglobulin A, is known to be important in resistance to respiratory viruses such as respiratory syncytial virus (22) , influenza virus (27) , and rhinoviruses (24) . Live replicating antigen is superior to inactivated antigen in eliciting local immunity in other systems (23, 25, 26) and may be a factor in the superior resistance elicited by TC-83. Virulent VEE is often considered to be a neurotropic virus, and it further exhibits significant infectivity via the respiratory tract. The potential of VEE virus to invade the central nervous system via the cribriform plate has been documented for nonhuman primates (9, 10), and in hamsters VEE virus has been shown to invade the olfactory bulb (11). Local 
